유전체학 맞춤형 의료 시장 규모 조사 : 기술별, 검사 유형별, 최종 사용자 및 지역별 예측(2022-2032년)

Global Genomics Personalized Health Market is valued approximately at USD 9.17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.23% over the forecast period 2024-2032. Genomic personalized health represents a transformative approach to medical treatment, utilizing genetic information to tailor therapies and interventions to individual patients. This sophisticated methodology enables the identification of complex conditions and facilitates the development of specialized treatments and therapies based on genetic profiling. By integrating genomic data into healthcare, traditional medications that may be ineffective or have adverse effects on specific patient groups can be avoided, thereby enhancing treatment efficacy and patient safety.

The Global Genomics Personalized Health Market is driven by increasing demand for early diagnosis and the surge in investments in research and development activities. The early diagnosis of diseases through genetic profiling allows for timely and more effective intervention, significantly improving patient outcomes. Moreover, substantial investments in R&D are fostering innovations in genomics technologies, which are essential for the advancement of personalized health solutions. In addition, increasing focus on personalized medicine, coupled with the rapid advancements in genomic technologies, positions the genomics personalized health market for substantial growth. As healthcare providers and institutions continue to adopt these advanced systems, the market is expected to expand significantly, offering improved healthcare outcomes through tailored medical interventions. However, lack of skilled professionals is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Genomics Personalized Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market driven by elevated healthcare expenditure, heightened awareness, and the growing demand for personalized medicine. The region's robust market dynamics are further propelled by advancements in genomics technologies, the presence of major pharmaceutical companies and research organizations, and the high prevalence of chronic diseases. These factors collectively strengthen North America's leading position in the genomics personalized health market. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

• QIAGEN
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche AG
• Lonza Group
• Invitae Corp
• Genetic Technologies Limited
• Interleukin Genetics Inc.
• Eastern Biotech and Life Sciences
• DNA Genotek Inc.
• uBiome, Inc.
• XCode Life Sciences Private Limited

The detailed segments and sub-segment of the market are explained below:

By Technology

• NGS Platform
• RT-PCR
• Microarray
• Genetic Analyzer
• Others

By Test Type

• Oncology Testing
• Infectious Disease Testing
• Orphan Disease Testing
• Autoimmune Disease Testing
• Obstetrics Testing
• Others

By End User

• Academics & Research Institutes
• Diagnostic Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Genomics Personalized Health Market Executive Summary

• 1.1. Global Genomics Personalized Health Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Technology
  • 1.3.2. By Test Type
  • 1.3.3. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Genomics Personalized Health Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Genomics Personalized Health Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rise in Demand for Early Diagnosis
  • 3.1.2. Increase in Investment in R&D Activities
• 3.2. Market Challenges
  • 3.2.1. Lack of Skilled Professionals
• 3.3. Market Opportunities
  • 3.3.1. Technological Advancements in Genomics
  • 3.3.2. Expansion in Emerging Markets

Chapter 4. Global Genomics Personalized Health Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Genomics Personalized Health Market Size & Forecasts by Technology 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Genomics Personalized Health Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. NGS Platform
  • 5.2.2. RT-PCR
  • 5.2.3. Microarray
  • 5.2.4. Genetic Analyzer
  • 5.2.5. Others

Chapter 6. Global Genomics Personalized Health Market Size & Forecasts by Test Type 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Genomics Personalized Health Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Oncology Testing
  • 6.2.2. Infectious Disease Testing
  • 6.2.3. Orphan Disease Testing
  • 6.2.4. Autoimmune Disease Testing
  • 6.2.5. Obstetrics Testing
  • 6.2.6. Others

Chapter 7. Global Genomics Personalized Health Market Size & Forecasts by End User 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Genomics Personalized Health Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Academics & Research Institutes
  • 7.2.2. Diagnostic Centers
  • 7.2.3. Others

Chapter 8. Global Genomics Personalized Health Market Size & Forecasts by Region 2022-2032

• 8.1. North America Genomics Personalized Health Market
  • 8.1.1. U.S. Genomics Personalized Health Market
    • 8.1.1.1. Technology breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Test Type breakdown size & forecasts, 2022-2032
    • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Genomics Personalized Health Market
    • 8.1.2.1. Technology breakdown size & forecasts, 2022-2032
    • 8.1.2.2. Test Type breakdown size & forecasts, 2022-2032
    • 8.1.2.3. End User breakdown size & forecasts, 2022-2032
• 8.2. Europe Genomics Personalized Health Market
  • 8.2.1. U.K. Genomics Personalized Health Market
  • 8.2.2. Germany Genomics Personalized Health Market
  • 8.2.3. France Genomics Personalized Health Market
  • 8.2.4. Spain Genomics Personalized Health Market
  • 8.2.5. Italy Genomics Personalized Health Market
  • 8.2.6. Rest of Europe Genomics Personalized Health Market
• 8.3. Asia-Pacific Genomics Personalized Health Market
  • 8.3.1. China Genomics Personalized Health Market
  • 8.3.2. India Genomics Personalized Health Market
  • 8.3.3. Japan Genomics Personalized Health Market
  • 8.3.4. Australia Genomics Personalized Health Market
  • 8.3.5. South Korea Genomics Personalized Health Market
  • 8.3.6. Rest of Asia Pacific Genomics Personalized Health Market
• 8.4. Latin America Genomics Personalized Health Market
  • 8.4.1. Brazil Genomics Personalized Health Market
  • 8.4.2. Mexico Genomics Personalized Health Market
  • 8.4.3. Rest of Latin America Genomics Personalized Health Market
• 8.5. Middle East & Africa Genomics Personalized Health Market
  • 8.5.1. Saudi Arabia Genomics Personalized Health Market
  • 8.5.2. South Africa Genomics Personalized Health Market
  • 8.5.3. Rest of Middle East & Africa Genomics Personalized Health Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. QIAGEN
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Illumina, Inc.
  • 9.3.3. Thermo Fisher Scientific, Inc.
  • 9.3.4. Bio-Rad Laboratories, Inc.
  • 9.3.5. Hoffmann-La Roche AG
  • 9.3.6. Lonza Group
  • 9.3.7. Invitae Corp
  • 9.3.8. Genetic Technologies Limited
  • 9.3.9. Interleukin Genetics Inc.
  • 9.3.10. Eastern Biotech and Life Sciences
  • 9.3.11. DNA Genotek Inc.
  • 9.3.12. uBiome, Inc.
  • 9.3.13. XCode Life Sciences Private Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes